Page 1 of Clinical Trials for Rivastigmine, 68 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Not yet recruiting
A Double-Blind, Placebo-Controlled Crossover Study of Repeat Rivastigmine (Exelon®) Administration in Young Healthy Male Volunteers
Last Updated: February 15, 2008
Condition(s): Rivastigmine Toxicity
2
Completed
Rivastigmine as a Treatment for Methamphetamine Dependence
Last Updated: February 20, 2012
Condition(s): Methamphetamine Dependence; Substance Abuse; Methamphetamine Abuse
3
Recruiting
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Last Updated: February 20, 2012
Condition(s): Cocaine Dependence; Cocaine Addiction; Cocaine Abuse; Substance Abuse
4
Completed
Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
Last Updated: October 19, 2011
Condition(s): Parkinson's Disease Dementia
5
Completed
Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients
Last Updated: March 19, 2012
Condition(s): Alzheimer Disease
6
Not yet recruiting
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
Last Updated: April 24, 2012
Condition(s): Alzheimer's Dementia
7
Recruiting
Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients
Last Updated: March 8, 2011
Condition(s): Alzheimer's Disease
8
Completed
Rivastigmine Prophylaxis in Elderly Patients Undergoing Major Surgery
Last Updated: October 5, 2010
Condition(s): Delirium; Postoperative Cognitive Dysfunction
9
Recruiting
Rivastigmine Study in Adolescents With Down Syndrome
Last Updated: March 20, 2012
Condition(s): Down Syndrome
10
Completed
Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Last Updated: February 24, 2011
Condition(s): Alzheimer's Disease
11
Completed
Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease
Last Updated: April 10, 2012
Condition(s): Alzheimer's Disease
12
Completed
A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
Last Updated: June 27, 2011
Condition(s): Alzheimer's Disease
13
Completed
Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions
Last Updated: January 12, 2012
Condition(s): Healthy
14
Completed
Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions
Last Updated: June 16, 2010
Condition(s): Healthy
15
Completed
Exelon Patch and Combination With Memantine Comparative Trial
Last Updated: May 18, 2010
Condition(s): Alzheimer's Disease
16
Recruiting
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease
Last Updated: April 24, 2012
Condition(s): Alzheimer's Disease
17
Completed
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
Last Updated: May 27, 2011
Condition(s): Alzheimer's Disease
18
Completed
Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Last Updated: September 27, 2011
Condition(s): Alzheimer's Disease
19
Completed
Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
Last Updated: December 17, 2007
Condition(s): Alzheimer's Disease
20
Active, not recruiting
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
Last Updated: November 22, 2011
Condition(s): Alzheimer's Disease

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Rivastigmine

Page 1 of Clinical Trials for Rivastigmine, 68 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About